← FDA Drug Approvals (Drugs@FDA)

IVERMECTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS LIFESCIENCES · Approved 2026-02-26

Drug application

FDA Application #
ANDA216863
Application type
Abbreviated New Drug Application (Generic)
Brand name
IVERMECTIN
Generic name
IVERMECTIN
Active ingredients
IVERMECTIN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
ZYDUS LIFESCIENCES
Manufacturer
Zydus Lifesciences Limited
First approval
2026-02-26

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown